Introduction
============

Recently, five randomized clinical trials of endovascular acute reperfusion therapy against medical treatment have established the benefit of the endovascular treatment in patients with proximal artery occlusions.^[@B1]--[@B5]^ All trials have shown a substantial reduction in disability at 90 days after treatment. Based on these results, the American Heart Association/American Stroke Association (AHA/ASA) provided a focused update of the current recommendations for the endovascular treatment of acute ischemic stroke.^[@B6]^ It recommends that the patients who meet the criteria should receive endovascular therapy with a stent retriever.

In Japan, the Japan Stroke Society, the Japan Neurosurgical Society, and the Japanese Society for Neuroendovascular Therapy (JSNET) jointly published a guideline concerning the proper use of embolectomy devices for acute ischemic stroke (version 2) in April, 2015.^[@B7]^ It recommends that a specialist certificated by the Specialist Qualification System of the JSNET^[@B8]^ or a physician who has managed at least 100 cases with neuroendovascular treatment should perform the recanalization therapy. Although there are 14 hospitals regarded as primary stroke centers (PSCs), in which there is uninterrupted availability of intravenous rtPA therapy in Ishikawa prefecture, neuroendovascular therapy specialists work full-time in only four hospitals. Therefore, we established a Kanazawa mobile embolectomy team (KMET), which could travel to these hospitals and perform reperfusion therapy. In this article, we report treatment outcomes in the initial stage and validate the effectiveness of a network between affiliated hospitals and KMET.

Materials and Methods
=====================

Organization of KMET
--------------------

KMET was organized by two consulting specialists (NU, MM), one specialist (KM), and one fellow (TK) acknowledged by the JSNET in January 2014. All members are board certified Japanese Neurosurgeons who work full-time in the department of Neurosurgery at Kanazawa University Hospital (KUH).

Treatment
---------

When a stroke patient arrived at an affiliated hospital of KUH, which was thought to be equivalent to a PSC, the physician of first contact in the PSC started intravenous r-tPA therapy if patients were eligible, and call the KMET if the patient met the following criteria, 1) causative occlusion of the internal carotid artery (ICA), middle cerebral artery (MCA), vertebral artery (VA), or basilar artery (BA), 2) Age ≥18 years, 3) NIHSS ≥5, 4) Alberta Stroke Programme Early Computed Tomography Score (ASPECTS)+W (which is proposed by the ASIST-JAPAN; <http://assist.umin.jp/>) ≥5, and 6) treatment can be initiated (groin puncture) within 6 hours of symptom onset. Two members of the KMET went to the PSC immediately following the call from the PSC. The physician in the PSC obtained informed written consent from the patient or a legal representative before treatment. The physician and KMET then performed acute reperfusion therapy together.

Statistics
----------

We recorded baseline characteristics, time intervals, and interventional procedural data as well as outcome. In detail this comprised age, sex, pretreatment NIHSS score, ASPECTS+W, site of large vessel occlusion, onset time (or last known normal time), patient arrival time, time of MRI, time of the call to KMET, when iv-rtPA was started, time of groin puncture and recanalization, type of reperfusion treatment and devices, result of recanalization (thrombolysis in cerebral infarction: TICI), and disability (modified Rankin Scale: mRS) at 90 days following treatment. The data are expressed as means unless indicated otherwise.

The patients were divided by the mRS score into the good outcome group (mRS score from 0 to 2) or the poor outcome one (mRS score from 3 to 6). Various time intervals were compared between the two groups using Student's *t* test. The cause of stroke, site of vessel occlusion, TICI grade, and distance from KUH to the PSC were compared between the two groups using chi-square test. Additionally, the patients were divided by onset to recanalization (O2R) time into three groups---less than 4 h, from 4 to 5 h, and above 5 h. The proportion of the patients with good outcome were compared between the three groups using Kruskal-Wallis test. Odds ratios (ORs) of good outcome with corresponding 95% confidence intervals (CIs) were calculated by using univariate and multivariate logistic regression for the following four clinical characteristics: NIHSS \<20, ASPECTS+W ≥8, onset to recanalization \<240 min, and TICI 2b or 3.

Standard statistical tests \[Student's *t* test, chi-square test, and the Kruskal-Wallis test (for non-parametric data)\] were applied when applicable. Logistic regression was used for univariate and multivariate analyses. P values less than or equal to the α level of 0.05 were considered significant. All statistical analyses were performed using SPSS 20 software (IBM, Armonk, NY, USA).

Results
=======

Between January 2014 and December 2015, 48 patients underwent acute reperfusion therapy provided by KMET for acute ischemic stroke in 10 affiliated hospitals of KUH. Ishikawa Prefectural Central Hospital, Kanazawa Municipal Hospital, Kanazawa Medical Center, Asanogawa General Hospital, and Kanazawa Neurosurgical Hospital in Ishikawa central medical district are located within 20 km of KUH. Komatsu Municipal Hospital in South Kaga medical district, Keiju Medical Center and Noto General Hospital in Middle Noto medical district are located between 20 and 80 km from KUH. Suzu General Hospital in North Noto medical district and Toyama Rosai Hospital in Toyama prefecture are further than 80 km from KUH ([Fig. 1](#F1){ref-type="fig"}). These hospitals function as PSCs in Ishikawa and Toyama prefecture.

Patient characteristics are summarized in [Table 1](#T1){ref-type="table"}. The patients were 36 males and 12 females, aged 45 to 92 years (mean: 73.0 years). Sites of occlusion included the ICA in 22 patients, proximal MCA in 11 patients, distal MCA in eight patients, VA in one patient, and BA in six patients. Pre-treatment NIHSS score ranged from 5 to 39 (mean: 19.1). ASPECTS+W ranged from 1 to 11 (mean: 7.3). Three patients underwent carotid artery stenting (CAS) for atherothrombotic occlusion of the ICA. All but the three patients received mechanical thrombectomy. Devices used in this study included the Penumbra system (Penumbra Inc., Alameda, CA, USA) in 19 patients, the Trevo ProVue Retriever (Stryker Neurovascular, Fremont, CA, USA) in 13 patients, Merci (Stryker Neurovascular, Fremont, CA, USA) in one patient and a combination of the Penumbra system and the Trevo ProVue Retriever in 12 patients.

Overall successful revascularization, defined as TICI 2b or 3, was achieved in 38/48 patients (80%), and a good outcome, defined as mRS score from 0 to 2, was achieved in 24/48 patients (50%) ([Fig. 2](#F2){ref-type="fig"}). There were two cases of intracranial bleeding (4%). The bleeding was caused by vessel perforation in one case, and hemorrhagic transformation in the other case. The former was symptomatic. The overall mortality rate at 90 days was 8% (4/48).

Mean time from onset to patient arrival was 67 min, mean time from hospital arrival to MRI was 62 min, mean time from MRI to calling the KMET was 35 min, mean time from the call to the KMET to iv-rtPA was 2 min, mean time from iv-rtPA to groin puncture was 58 min, mean time from groin puncture to recanalization was 73 min, and mean time from onset to recanalization was 297 min ([Fig. 3](#F3){ref-type="fig"}). Comparison of characteristics between good and poor outcome groups are summarized in [Table 2](#T2){ref-type="table"}. Pre-treatment NIHSS score, ASPECT+W, TICI grade were significantly different between the two groups. Mean time from onset to recanalization of the good outcome and poor outcome groups were 291 min and 304 min, respectively, which were not significantly different. Various time intervals other than puncture to recanalization were not significantly different.

The relationship between rates of good outcome and O2R time is shown in [Table 3](#T3){ref-type="table"}. When O2R was less than 4 h, there was a good outcome 62% in all patients. It decreased to 42%, when O2R was from 4 to 5 h. However, it increased again to 50%, when O2R was more than 5 h. As analyzed by cause of stroke, the rate of good outcome in the 38 patients with cardioembolic occlusion (CEO) gradually decreased as O2R time increased (58%→47%→36%), although it was not statistically significant. On the other hand, there was no relationship between the rate of eight patients with atherothrombotic occlusion (ATO) and the time course (100%→33%→100%).

The relative contribution of different variables to good outcome at 90 days is shown in [Table 4](#T4){ref-type="table"}. On univariate analysis, baseline NIHSS score \<20, ASPECTS+W ≥8, and TICI 2b or 3 were significantly associated with a good outcome at 90 days. The multivariate logistic regression analysis identified ASPECTS+W ≥8 (OR, 4.46; 95% CI, 1.116--17.82, p = 0.0344), and TICI 2b or 3 (OR, 8.204; 95% CI, 1.146--58.71, p = 0.0361) as independent factors for a good outcome at 90 days.

Discussion
==========

The rate of revascularization in our study was 80%, similar to five previously published randomized controlled trials (RCTs), ranging from 59% in MR CLEAN to 86% in EXTEND-IA and 88% in SWIFT PRIME.^[@B1]--[@B5]^ The good outcome rate, defined as mRS 0--2 at 90 days after treatment, was 50%, again similar to the RCTs, ranging from 33% in MR CLEAN to 71% in EXTEND-IA ([Table 5](#T5){ref-type="table"}).^[@B1]--[@B5]^ These results indicate that acute recanalization therapy of the KMET can be safely applied under real-world conditions in our local area.

Although improved clinical outcomes are observed with decreased time to reperfusion in general, there was no significant difference in the total time course between the good outcome group and the poor outcome one in our study. Only time from puncture to recanalization in the poor outcome group was significantly longer than that in the good outcome one, because it took more time for refractory cases in which occluded vessels could not be opened in the poor outcome group. In patients with CEO, the greater the time to reperfusion extended, the lower the better outcome rate decreased. On the other hand, all patients with ATO achieved a good outcome, even if the time to reperfusion was more than 5 h. Most cases of ATO have better collateral flow compare to CEO, in particular in cases of vertebrobasilar occlusion.^[@B9]^ In fact, three cases of atherothrombotic basilar occlusion in this study, whose time from onset to recanalization was 280--666 min, had a good outcome. The relatively high proportion of such patients with ATO (22%) in our study might make the relationship between the time course and the outcome obscure.

Time from onset to groin puncture is one of the most important time-interval metrics. The mean and median time from onset to groin puncture in our study were 224 and 205 min, respectively. Though it took about 60--70 min for the KMET to reach the affiliated hospitals, the median time of 205 min is similar to those in the five published RCTs, ranging from 200 min in ESCAPE to 269 min in REVASCAT ([Table 5](#T5){ref-type="table"}). This result suggests that the treatment system of a mobile embolectomy team does not extend the total time of the recanalization therapy. Furthermore, we may reduce time to revascularization. Mean time from patient arrival to MRI and to groin puncture in our study were 67 and 157 min, 42 and 37 min longer than the recommended time,^[@B10]^ respectively. We will be able to reduce the door-to-imaging (MRI) time after carefully investigating workflow in the PSC. In addition, physicians in the PSC should call the KMET immediately after learning of large vessel occlusion on MRI. The sooner the KMET depart to the affiliated hospital, the earlier the endovascular treatment can start. Reduction of the total time from onset to recanalization can increase the rate of patients with favorable outcome.^[@B11]^

In our study, relatively small ischemic lesions (ASPECTS+W ≥8) and good recanalization (TICI 2b or 3) were factors significantly associated with a 90-day good outcome. These results are consistent with the previous reports.^[@B12]^ We treated the 10 patients with an ASPECTS+W score less than 6. Although all but one patient could not independently perform activities of daily living, conventional conservative therapy alone may worsen their prognosis. As indicated by the AHA/ASA guidelines, the endovascular recanalization therapy may be reasonable for patients with a low ASPECTS score, if the treatment can be initiated within 6 h of symptom onset.^[@B6]^

In summary, total time course and treatment results of acute reperfusion therapy provided by KMET were almost the same as those reported in five recently published RCTs. Our findings suggest that a collaborative network between affiliated hospitals and KMET is effective for acute reperfusion therapy in a local area wherein experienced neuroendovascular specialists are insufficient.
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###### 

Patient characteristics

  ------------------------------------- ------------
  Patient no.                           48
  Age (mean ± SD)                       73.0 ± 8.9
  Male sex no. (%)                      36 (75)
  NIHSS (mean ± SD)                     19.1 ± 7.8
  ASPECTS+W (mean ± SD)                 7.3 ± 2.4
  Cause of stroke -- no. (%)            
    Cardioembolic occlusion             38 (79)
    Atherothrombotic occlusion          8 (17)
    Dissection                          2 (4)
  Site of vessel occlusion -- no. (%)   
    Internal carotid artery             22 (46)
    Proximal middle cerebral artery     11 (23)
    Distal middle cerebral artery       8 (17)
    Vertebral artery                    1 (2)
    Basilar artery                      6 (12)
  ------------------------------------- ------------

ASPECTS: Alberta Stroke Program Early Computed Tomography Score, NIHSS: National Institutes of Health Stroke Scale.

###### 

Comparison of characteristics between good and poor outcome groups

                                       Good outcome    Poor outcome   p
  ------------------------------------ --------------- -------------- --------
  Patient no.                          24              24             
  Age (mean ± SD)                      73.3 ± 8.1      72.8 ± 9.9     0.8484
  Male sex no. (%)                     21 (88)         15 (63)        0.0956
  NIHSS (mean ± SD)                    16.0 ± 7.4      22.2 ± 7.1     0.0051
  ASPECTS+W (mean ± SD)                8.4 ± 4.1       6.3 ± 2.2      0.001
  Cause of stroke - no. (%)                                           0.1284
    Cardioembolic occlusion            18 (75)         20 (84)        
    Atherothrombotic occlusion         6 (25)          2 (8)          
    Dissection                         0 (0)           2 (8)          
  Site of vessel occlusion - no. (%)                                  0.5334
    Internal carotid artery            9 (37)          13 (54)        
    Proximal middle cerebral artery    6 (25)          5 (21)         
    Distal middle cerebral artery      4 (17)          4 (17)         
    Vertebral artery                   1 (4)           0 (0)          
    Basilar artery                     4 (17)          2 (8)          
  Iv-rtPA                              11 (46)         13 (54)        0.7732
  TICI - no. (%)                                                      0.0244
    0                                  0 (0)           4 (17)         
    1                                  0 (0)           0 (0)          
    2A                                 2 (8)           4 (17)         
    2B                                 8 (33)          11 (46)        
    3                                  14 (59)         5 (20)         
  Time course - minutes (mean ± SD)                                   
    LKN to door                        70.4 ± 69.1     64.3 ± 67.6    0.7609
    Door to picture (MRI)              67.0 ± 30.7     57.7 ± 30.4    0.2958
    Door to call KMET                  101.0 ± 104.9   93.3 ± 51.0    0.7502
    Door to puncture                   159.4 ± 103.4   152.8 ± 43.5   0.775
    Puncture to recanalization         62.3 ± 25.5     83.8 ± 34.1    0.0175
    LKN to needle (iv-rtPA)            149.6 ± 41.7    157.6 ± 45.6   0.6612
    LKN to puncture                    228.1 ± 110.2   220.0 ± 75.3   0.7691
    LKN to recanalization              290.9 ± 109.9   303.8 ± 88.5   0.6548
  Distance from KUH - no. (%)                                         0.083
    ≤20 km                             16 (67)         9 (38)         
    \>20 km                            8 (33)          15 (62)        

ASPECTS: Alberta Stroke Program Early Computed Tomography Score, TICI: thrombolysis in cerebral infarction, LKN: last known normal, KUH: Kanazawa University Hospital, KMET: Kanazawa mobile embolectomy team.

###### 

Relationship between onset to recanalization (O2R) time and good outcome rate

                      O2R           \<4 h   4--5 h   5 h\<   P value
  ------------------- ------------- ------- -------- ------- ---------
  CEO                 patient no.   12      15       11      0.5773
  mRS 0-2             7             7       4                
  good outcome rate   58%           47%     36%              
  ATO                 patient no.   1       3        4       0.3292
  mRS 0-2             1             1       4                
  good outcome rate   100%          33%     100%             
  Total               patient no.   13      19       16      0.6516
  mRS 0-2             8             8       8                
  good outcome rate   62%           42%     50%              

ATO: atherothrombotic occlusion, CEO: cardioembolic occlusion, mRS: modified Rankin Scale.

###### 

Results of possible factors for a good outcome after acute recanalization therapy using univariate logistic regression analysis

  Variables                           n    Odds ratio   95% CI (min--max)   p
  ----------------------------------- ---- ------------ ------------------- --------
  NIHSS ≤20                           26   4.0          1.210--13.539       0.0232
  ASPECT+W ≥ 8                        26   6.0          1.711--21.040       0.0051
  Onset to recanalization ≤ 240 min   13   1.9          0.518--6.975        0.4175
  TICI 2B & 3                         38   5.5          1.027--29.456       0.0465

ASPECTS: Alberta Stroke Program Early Computed Tomography Score, NIHSS: National Institutes of Health Stroke Scale, TICI: thrombolysis in cerebral infarction.

###### 

Summary of results of the present study and recent randomized control trials in endovascular thrombectomy for ischemic stroke

                n     Median onset-to-groin puncture time (min)   TICI 2b or 3   mRS 0-2 at 90 days   Mortality at 90 days
  ------------- ----- ------------------------------------------- -------------- -------------------- ----------------------
  MR CLEAN      233   260                                         59%            33%                  21%
  EXTEND IA     35    210                                         86%            71%                  9%
  ESCAPE        165   200                                         72%            53%                  10%
  SWIFT PRIME   98    224                                         88%            60%                  9%
  REVASCAT      103   269                                         66%            44%                  18%
  KMET          48    205                                         80%            50%                  8%

mRS: modified Rankin Scale, TICI: thrombolysis in cerebral infarction.
